Placebo News and Research

RSS

Study explores how to predict and prevent psychiatric morbidity in survivors of ARDS

After surviving acute respiratory distress syndrome, a disease in which fluid begins to leak into the lungs of critically ill patients and makes it difficult to breathe, many patients develop mental illness.

5 Apr 2017

MPA approves Renishaw study into chronic drug delivery system in Parkinson's patients

The Medicines Agency of Sweden, MPA, has authorised Herantis Pharma Plc and Renishaw plc’s randomised, placebo-controlled Phase 1-2 clinical study, for the investigation of Cerebral Dopamine Neurotrophic Factor (CDNF) and Renishaw’s chronic drug delivery system, in Parkinson’s patients.

4 Apr 2017

Study reveals potential new approach to treat posttraumatic stress disorder

A potential new approach to treat posttraumatic stress disorder: After taking the antibiotic doxycycline, study participants remembered an unpleasant event considerably less, as experiments conducted by a team of researchers from the University Psychiatric Hospital and the University of Zurich reveal.

4 Apr 2017

Common antibiotic can disrupt formation of negative associations in the brain, research reveals

The common antibiotic doxycycline can disrupt the formation of negative associations in the brain, according to new research from UCL and the University of Zurich.

4 Apr 2017

New drug compound could cut number of hot flushes in menopausal women

Women plagued by frequent hot flushes during the menopause could cut the number of flushes by almost three-quarters, thanks to a new drug compound.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine.

31 Mar 2017

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Vaccinations have begun in a multi-site Phase 2/2b clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika infection.

31 Mar 2017

Balance test can temporarily alleviate common symptom in schizophrenia patients

A common symptom of schizophrenia - not knowing that you're ill -- can be temporarily alleviated using a balance test that stimulates part of the brain with cold water, an exploratory study at the Centre for Addiction and Mental Health has shown.

30 Mar 2017

Single dose of siRNA molecule offers protection against heart attack and stroke in high-risk patients

Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol - one of the main risk factors for heart attack and stroke.

30 Mar 2017

Study examines effects of vitamin C doses on duration of common cold

The relationship between vitamin C dosage and its effects on the duration of the common cold symptoms may extend to 6-8 grams per day according to a statistical analysis published in Nutrients.

30 Mar 2017

FDA approves new therapy for adult patients with relapsing and primary progressive MS

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

29 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

SNIFF study to examine safety, efficacy of nasal insulin for treating Alzheimer’s disease

Can insulin, the hormone used for nearly a century to treat diabetes, improve cognition, memory and daily function in people with mild cognitive impairment or mild dementia due to Alzheimer's disease? Rush University Medical Center is testing this innovative potential treatment as part of a new nationwide study.

25 Mar 2017

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

A federal health agency has found certain antidepressants and anti-seizure drugs are among medications that effectively treat diabetic nerve pain.

25 Mar 2017

IQWiG assesses potential of MRI-guided high-intensity focused ultrasound therapy for uterine fibroids

For the first time since the corresponding law became effective in 2012, the German Institute for Quality and Efficiency in Health Care has published an assessment of the potential of a new treatment method according to §137e of Social Code Book V.

23 Mar 2017

Study evaluates screening and treatment for subclinical thyroid disease during pregnancy

Observational studies over the past 30 years suggest that subclinical thyroid disease during pregnancy may be associated with adverse outcomes, including a lower-than-normal IQ in offspring.

22 Mar 2017

Study shows efficacy of biologics for mucosal healing in Crohn's disease and ulcerative colitis

Although anti-inflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis, the mucosal lining of the intestine often remains ulcerated, and many patients still ultimately require surgery.

22 Mar 2017

Study to assess effectiveness of two OTC medications for treating alcoholism in bipolar patients

Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.

22 Mar 2017

FDA approves drug as add-on treatment for Parkinson's disease patients

The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson's disease who are currently taking levodopa/carbidopa and experiencing "off" episodes.

21 Mar 2017

Placebo News and Research

Study explores how to predict and prevent psychiatric morbidity in survivors of ARDS

MPA approves Renishaw study into chronic drug delivery system in Parkinson's patients

Study reveals potential new approach to treat posttraumatic stress disorder

Common antibiotic can disrupt formation of negative associations in the brain, research reveals

New drug compound could cut number of hot flushes in menopausal women

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Balance test can temporarily alleviate common symptom in schizophrenia patients

Single dose of siRNA molecule offers protection against heart attack and stroke in high-risk patients

Study examines effects of vitamin C doses on duration of common cold

FDA approves new therapy for adult patients with relapsing and primary progressive MS

FDA approves new maintenance therapy for recurrent cancers

SNIFF study to examine safety, efficacy of nasal insulin for treating Alzheimer’s disease

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

IQWiG assesses potential of MRI-guided high-intensity focused ultrasound therapy for uterine fibroids

Study evaluates screening and treatment for subclinical thyroid disease during pregnancy

Study shows efficacy of biologics for mucosal healing in Crohn's disease and ulcerative colitis

Study to assess effectiveness of two OTC medications for treating alcoholism in bipolar patients

FDA approves drug as add-on treatment for Parkinson's disease patients

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News